FFA
IDXX icon

Farther Finance Advisors’s Idexx Laboratories IDXX Stock Holding History

Farther Finance Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04M Buy
3,871
+1,278
+49% +$717K 0.02% 733
2026
Q1 		$1.46M Sell
2,593
-690
-21% -$442K 0.01% 782
2025
Q4 		$2.22M Sell
3,283
-182
-5% -$124K 0.02% 545
2025
Q3 		$2.21M Buy
3,465
+348
+11% +$211K 0.03% 421
2025
Q2 		$1.67M Buy
3,117
+1,040
+50% +$497K 0.03% 420
2025
Q1 		$869K Buy
2,077
+1,440
+226% +$625K 0.02% 566
2024
Q4 		$263K Sell
637
-168
-21% -$73.7K 0.01% 866
2024
Q3 		$407K Buy
805
+105
+15% +$51K 0.02% 680
2024
Q2 		$334K Buy
700
+305
+77% +$153K 0.02% 630
2024
Q1 		$210K Buy
395
+121
+44% +$66.1K 0.01% 667
2023
Q4 		$152K Buy
274
+184
+204% +$86.4K 0.01% 647
2023
Q3 		$39.4K Buy
90
+40
+80% +$19.9K 0.01% 851
2023
Q2 		$25.1K Buy
50
+2
+4% +$958 0.01% 921
2023
Q1 		$24K Buy
48
+4
+9% +$1.91K 0.01% 841
2022
Q4 		$17.9K Buy
+44
New +$17.1K 0.01% 770

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Farther Finance Advisors's IDXX Position: Q2 2026 in Review

Farther Finance Advisors increased its Idexx Laboratories (IDXX) stake by 49% in Q2 2026, buying an estimated $717K and bringing the position to 3,871 shares worth $2.04M. The position accounts for 0.02% of the portfolio, ranked #733.

Farther Finance Advisors first reported a position in IDXX in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.22M in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Farther Finance Advisors held 3,871 shares of Idexx Laboratories worth $2.04M as of Q2 2026.
  • Farther Finance Advisors bought 1,278 Idexx Laboratories shares in Q2 2026, an estimated $717K.
  • Idexx Laboratories made up 0.02% of Farther Finance Advisors's portfolio in Q2 2026, its #733 holding.
  • Farther Finance Advisors first reported a position in Idexx Laboratories in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's Idexx Laboratories position peaked at $2.22M in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.